The factors driving therapy resistance in diffuse glioma remain poorly understood. To
identify treatment-associated cellular and genetic changes, we analyzed RNA and/or DNA …

Purpose: To present comprehensive examinations of the assumptions made in functional
diffusion map (fDM) analyses and provide a biological basis for fDM classification. Materials …

Introduction What is the current status of photodynamic therapy (PDT) with regard to treating
malignant brain tumors? Despite several decades of effort, PDT has yet to achieve standard …

Primary brain tumors, whether malignant or nonmalignant, have devastating consequences.
Unfortunately, few known causes exist. Despite decades of epidemiologic research to …

Glioblastoma remains the most common, malignant primary cancer of the central nervous
system with a low life expectancy and an overall survival of less than 1.5 years. The treatment …

Anti-angiogenic agents targeting brain tumor neovasculature may increase progression-free
survival in patients with recurrent malignant gliomas. However, when these patients do …

The goal of this study is to spatially discriminate tumor from treatment effect (TE), within the
contrast-enhancing lesion, for brain tumor patients at all stages of treatment. To this end, the …

BACKGROUND AND PURPOSE: DSC-MR imaging using preload, intermediate (60) flip
angle and postprocessing leakage correction has gained traction as a standard methodology. …

Cancer is a complex disease; glioblastoma (GBM) is no exception. Short survival, poor
prognosis, and very limited treatment options make it imperative to unravel the disease …

Glioblastoma multiforme (GBM) is the most common primary, intracranial malignancy of the
central nervous system. The standard treatment protocol, which involves surgical resection, …